Reporter May 15 2020

Probing innate immunity

Manuel Ascano team validates an inhibitor of the cGAS-STING signaling pathway, which is important for cellular innate immunity against bacteria, viruses, and our own damaged DNA.

Implant one day may replace dialysis

Vanderbilt researchers used pharmacological manipulations to increase salt and water transport by kidney cells grown in culture, a step necessary for realizing an implantable artificial kidney device.

Jeff Balser, MD, PhD, talks with veteran journalist John Seigenthaler Jr. during the filming of this week’s Leadership Assembly.

Core principles guiding the COVID-19 response and beyond

During a first-ever virtual leadership assembly necessitated through social distancing, Vanderbilt University Medical Center leaders answered questions about the Medical Center’s response to COVID-19 so far and what the future could hold.

Antibodies eye Pacific Island “fever”

Vanderbilt Vaccine Center team isolates monoclonal antibodies against Ross River virus, which causes rash, fever and debilitating muscle and joint pain lasting three to six months.

The adaptable anthrax bacterium

Vanderbilt researchers discover how anthrax bacterium defends itself against structural damage and resists the toxicity of the antimicrobial drug targocil.

VUMC Farmers’ Market opening postponed

The VUMC Farmers’ Market, which usually opens in early June on the Medical Center plaza, will delay its opening due to the coronavirus pandemic.

1 2